Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses

Cell Metabolism

Volumn 11, Issue 6, 2010, Pages 532-542

  Cox, Helen M ^a   Tough, Iain R ^a   Woolston, Anne Marie ^a   Zhang, Lei ^b   Nguyen, Amy D ^b   Sainsbury, Amanda ^b,c   Herzog, Herbert ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

HUMDISEASE

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCOSE; PEPTIDE YY [3-36]; PROTEIN GPR119; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; ELECTROLYTE; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GPR119 PROTEIN, HUMAN; GPR119 PROTEIN, MOUSE; HETEROCYCLIC CARBOXYLIC ACID; NEUROPEPTIDE Y RECEPTOR; OXADIAZOLE DERIVATIVE; PEPTIDE YY; PSN 632408;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; COLON; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENTEROENDOCRINE CELL; GENETICS; METABOLISM; MOUSE MUTANT; STOMACH MUCOSA;

MUS;

ACIDS, HETEROCYCLIC; ANIMALS; COLON; ELECTROLYTES; ENTEROENDOCRINE CELLS; GASTRIC MUCOSA; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; MICE; MICE, KNOCKOUT; OXADIAZOLES; PEPTIDE YY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE Y;

EID: 77956397360     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.04.014     Document Type: Article

References (45)

1. C.R. Abbott, C.J. Small, A. Sajedi, K.L. Smith, J.R. Parkinson, L.L. Broadhead, M.A. Ghatei, and S.R. Bloom The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat Int. J Obes. (Lond) 30 2006 288 292
2. T.E. Adrian, G.L. Ferri, A.J. Bacarese-Hamilton, H.S. Fuessl, J.M. Polak, and S.R. Bloom Human distribution and release of a putative new gut hormone, peptide YY Gastroenterology 89 1985 1070 1077
3. B. Ahrén Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes Nat. Rev. Drug Discov. 8 2009 369 385
4. B. Ahrén, M. Landin-Olsson, P.-A. Jansson, M. Svensson, D. Holmes, and A. Schweizer Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes J. Clin. Endocrinol. Metab. 89 2004 2078 2084
5. Y. Anini, X. Fu-Cheng, J.C. Cuber, A. Kervran, J. Chariot, and C. Roz Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat Pflugers Arch. 438 1999 299 306
6. R.M.E. Arantes, and A.M.F. Nogueira Distribution of enteroglucagon- and peptide YY-immunoreactive cells in the intestinal mucosa of germ-free and conventional mice Cell Tissue Res. 290 1997 61 69
7. D. Boey, S. Lin, T. Karl, P. Baldock, N. Lee, R. Enriquez, M. Couzens, K. Slack, R. Dallmann, A. Sainsbury, and H. Herzog Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity Diabetologia 49 2006 1360 1370
8. D. Boey, A. Sainsbury, and H. Herzog The role of peptide YY in regulating glucose homeostasis Peptides 28 2007 390 395
9. G. Böttcher, K. Sjölund, E. Ekblad, R. Hkanson, T.W. Schwartz, and F. Sundler Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut Regul. Pept. 8 1984 261 266
10. Z.-L. Chu, R.M. Jones, H. He, C. Carroll, V. Gutierrez, A. Lucman, M. Moloney, H. Gao, H. Mondala, and D. Bagnol A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release Endocrinology 148 2007 2601 2609
11. Z.-L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, and D. Bagnol A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release Endocrinology 149 2008 2038 2047
12. H.M. Cox Neuropeptide Y receptors; antisecretory control of intestinal epithelial function Auton. Neurosci. 133 2007 76 85
13. 2-mediated absorption in human and mouse colon Nutrition 24 2008 900 906
14. 4 receptors mediate Y agonist responses in isolated human colon mucosa Br. J. Pharmacol. 135 2002 1505 1512
15. H.M. Cox, A.W. Cuthbert, R. Hkanson, and C. Wahlestedt The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia J. Physiol. 398 1988 65 80
16. H.M. Cox, E.L. Pollock, I.R. Tough, and H. Herzog Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa Peptides 22 2001 445 452
17. H.U. Demuth, C.H.S. McIntosh, and R.A. Pederson Type 2 diabetes - therapy with dipeptidyl peptidase IV inhibitors Biochim. Biophys. Acta 1751 2005 33 44
18. G.J. Dockray The versatility of the vagus Physiol. Behav. 97 2009 531 536
19. 1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium J. Neurochem. 105 2008 641 652
20. D.J. Drucker Biologic actions and therapeutic potential of the proglucagon-derived peptides Nat. Clin. Pract. Endocrinol. Metab. 1 2005 22 31
21. M.S. Engelstoft, K.L. Egerod, B. Holst, and T.W. Schwartz A gut feeling for obesity: 7TM sensors on enteroendocrine cells Cell Metab. 8 2008 447 449
22. J.V. Gardiner, C.N. Jayasena, and S.R. Bloom Gut hormones: a weight off your mind J. Neuroendocrinol. 20 2008 834 841
23. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, M. Yamada, Y. Sugimoto, S. Miyazaki, and G. Tsujimoto Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat. Med. 11 2005 90 94
24. 2 antagonism in mouse and human colonic tissues Br. J. Pharmacol. 139 2003 863 871
25. T. Karl, L. Duffy, and H. Herzog Behavioural profile of a new mouse model for NPY deficiency Eur. J. Neurosci. 28 2008 173 180
26. B. Kreymann, G. Williams, M.A. Ghatei, and S.R. Bloom Glucagon-like peptide-1 7-36: a physiological incretin in man Lancet 2 1987 1300 1304
27. A.-M. Lambeir, S. Scharpé, and I. De Meester DPP4 inhibitors for diabetes - what next? Biochem. Pharmacol. 76 2008 1637 1643
28. G.R. Lankas, B. Leiting, R.S. Roy, G.J. Eiermann, M.G. Beconi, T. Biftu, C.-C. Chan, S. Edmondson, W.P. Feeney, and H. He Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 Diabetes 54 2005 2988 2994
29. L.M. Lauffer, R. Iakoubov, and P.L. Brubaker GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell Diabetes 58 2009 1058 1066
30. C.D. Lauster, T.P. McKaveney, and S.V. Muench Vildagliptin: a novel oral therapy for type 2 diabetes mellitus Am. J. Health Syst. Pharm. 64 2007 1265 1273
31. 1 receptor expression in the epithelium and mucosal nerves of the human colon Regul. Pept. 83 1999 11 19
32. R. Mentlein, P. Dahms, D. Grandt, and R. Krüger Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul. Pept. 49 1993 133 144
33. C. Mongardi Fantaguzzi, M. Thacker, R. Chiocchetti, and J.B. Furness Identification of neuron types in the submucosal ganglia of the mouse ileum Cell Tissue Res. 336 2009 179 189
34. H.A. Overton, A.J. Babbs, S.M. Doel, M.C. Fyfe, L.S. Gardner, G. Griffin, H.C. Jackson, M.J. Procter, C.M. Rasamison, and M. Tang-Christensen Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents Cell Metab. 3 2006 167 175
35. H.A. Overton, M.C.T. Fyfe, and C. Reynet GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity Br. J. Pharmacol. 153 Suppl 1 2008 S76 S81
36. R.A. Pittner, C.X. Moore, S.P. Bhavsar, B.R. Gedulin, P.A. Smith, C.M. Jodka, D.G. Parkes, J.R. Paterniti, V.P. Srivastava, and A.A. Young Effects of PYY[3-36] in rodent models of diabetes and obesity Int. J. Obes. Relat. Metab. Disord. 28 2004 963 971
37. R.J. Playford, J. Domin, J. Beacham, K.B. Parmar, K. Tatemoto, S.R. Bloom, and J. Calam Preliminary report: role of peptide YY in defence against diarrhoea Lancet 335 1990 1555 1557
38. F. Reimann, A.M. Habib, G. Tolhurst, H.E. Parker, G.J. Rogers, and F.M. Gribble Glucose sensing in L cells: a primary cell study Cell Metab. 8 2008 532 539
39. F. Sundler, E. Ekblad, and R. Hkanson Localization and colocalization of GI peptides D.R. Brown, Handbook of Experimental Pharmacology vol. 106 1993 Springer-Verlag Berlin 1 28
40. G. Tolhurst, F. Reimann, and F.M. Gribble Nutritional regulation of glucagon-like peptide-1 secretion J. Physiol. 587 2009 27 32
41. 4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa J. Pharmacol. Exp. Ther. 319 2006 20 30
42. 3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet Diabetes 53 2004 1949 1952
43. 3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice Am. J. Physiol. Endocrinol. Metab. 292 2007 E238 E245
44. K.E. Wortley, K. Garcia, H. Okamoto, K. Thabet, K.D. Anderson, V. Shen, J.P. Herman, D. Valenzuela, G.D. Yancopoulos, and M.H. Tschöp Peptide YY regulates bone turnover in rodents Gastroenterology 133 2007 1534 1543
45. L. Zhang, N.J. Lee, A.D. Nguyen, R.F. Enriquez, S.J. Riepler, B. Stehrer, E. Yulyaningsih, S. Lin, Y.C. Shi, and P.A. Baldock Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation Diabetes Obes. Metab. 2010 10.1111/j.1463-1326.2009.01193.x in press. Published online December 21, 2009